These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
84 related items for PubMed ID: 22020406
1. RNAi silencing of the MEKK3 gene promotes TRAIL-induced apoptosis in MCF-7 cells and suppresses the transcriptional activity of NF-κB. Guo SY, Liu SG, Liu L, Zhou XJ, Gu Y. Oncol Rep; 2012 Feb; 27(2):441-6. PubMed ID: 22020406 [Abstract] [Full Text] [Related]
2. PKCdelta protects human breast tumor MCF-7 cells against tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis. Zhang J, Liu N, Zhang J, Liu S, Liu Y, Zheng D. J Cell Biochem; 2005 Oct 15; 96(3):522-32. PubMed ID: 16114000 [Abstract] [Full Text] [Related]
3. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. Weldon CB, Parker AP, Patten D, Elliott S, Tang Y, Frigo DE, Dugan CM, Coakley EL, Butler NN, Clayton JL, Alam J, Curiel TJ, Beckman BS, Jaffe BM, Burow ME. Int J Oncol; 2004 Jun 15; 24(6):1473-80. PubMed ID: 15138590 [Abstract] [Full Text] [Related]
5. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells. Hermisson M, Weller M. Cell Death Differ; 2003 Sep 15; 10(9):1078-89. PubMed ID: 12934082 [Abstract] [Full Text] [Related]
12. TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration. Wang D, Liu D, Gao J, Liu M, Liu S, Jiang M, Liu Y, Zheng D. FEBS J; 2013 Jul 15; 280(14):3340-53. PubMed ID: 23647548 [Abstract] [Full Text] [Related]
15. Over-expressing CYLD augments antitumor activity of TRAIL by inhibiting the NF-κB survival signaling in lung cancer cells. Deng LL, Shao YX, Lv HF, Deng HB, Lv FZ. Neoplasma; 2012 Jul 15; 59(1):18-29. PubMed ID: 22017589 [Abstract] [Full Text] [Related]
16. Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells. Braeuer SJ, Büneker C, Mohr A, Zwacka RM. Mol Cancer Res; 2006 Oct 15; 4(10):715-28. PubMed ID: 17050666 [Abstract] [Full Text] [Related]
17. Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapy. Xu J, Zhou JY, Wu GS. Cancer Res; 2006 Oct 15; 66(20):10092-9. PubMed ID: 17047073 [Abstract] [Full Text] [Related]
18. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin. Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P. Clin Cancer Res; 2006 Feb 15; 12(4):1355-64. PubMed ID: 16489094 [Abstract] [Full Text] [Related]
19. 1'S-1'-acetoxyeugenol acetate: a novel phenylpropanoid from Alpinia conchigera enhances the apoptotic effects of paclitaxel in MCF-7 cells through NF-κB inactivation. In LL, Azmi MN, Ibrahim H, Awang K, Nagoor NH. Anticancer Drugs; 2011 Jun 15; 22(5):424-34. PubMed ID: 21346553 [Abstract] [Full Text] [Related]